Quest Diagnostics Inc Bank Overdrafts
Quest Diagnostics Inc (DGX) had Bank Overdrafts of $203.00 million as of 2025-12-31, per its 10-K filed 2026-02-26.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current › Debt, Current
us-gaap:BankOverdrafts · last filed 2026-02-26
- 2025-12-31: Bank Overdrafts $203.00M.
- 2024-12-31: Bank Overdrafts $162.00M.
- 2023-12-31: Bank Overdrafts $129.00M.
- 2022-12-31: Bank Overdrafts $92.00M.
| Period end | Bank Overdrafts |
|---|---|
| 2025-12-31 | $203.00M 10-K · filed 2026-02-26 |
| 2024-12-31 | $162.00M 10-K · filed 2026-02-26 |
| 2023-12-31 | $129.00M 10-K · filed 2025-02-20 |
| 2022-12-31 | $92.00M 10-K · filed 2024-02-22 |
| 2021-12-31 | $116.00M 10-K · filed 2023-02-21 |
| 2020-12-31 | $153.00M 10-K · filed 2022-02-28 |
| 2019-12-31 | $88.00M 10-K · filed 2021-02-22 |
| 2018-12-31 | $98.00M 10-K · filed 2020-02-20 |
| 2017-12-31 | $71.00M 10-K · filed 2019-02-21 |
| 2016-12-31 | $30.00M 10-K · filed 2018-02-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| LABCORP HOLDINGS INC. (LH) | United States | $25.060B | 22.60 |
| Guardant Health, Inc. (GH) | United States | $23.675B | -12.65 |
| Caris Life Sciences, Inc. (CAI) | United States | $9.119B | 47.87 |
| RadNet, Inc. (RDNT) | United States | $5.611B | -229.65 |
| GRAIL, Inc. (GRAL) | United States | $5.591B | -7.78 |
| VERACYTE, INC. (VCYT) | United States | $3.904B | 41.21 |
| Celcuity Inc. (CELC) | United States | $3.887B | -22.62 |
| CareDx, Inc. (CDNA) | United States | $3.174B | 13.21 |
| Fortrea Holdings Inc. (FTRE) | United States | $1.903B | -19.43 |
| Personalis, Inc. (PSNL) | United States | $1.769B | -13.30 |